Novartis has announced that, in a move to consolidate their eye disease research projects in the United States, it will be moving 120 jobs from the company’s Texas base in Forth Worth to Cambridge, Massachusetts. The decision means that the Swiss-based pharmaceutical company will be closing the doors on its Biomedical Research Group, which is based out of Alcon Labs in Fort Worth.
http://bionews-tx.com/news/2013/04/11/novartis-moving-120-fort-worth-jobs-to-massachusetts/
No comments:
Post a Comment